Business Context and Reporting Period
Company: Superior Surgical Mfg. Co., Inc. (Superior Group of Companies, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 1995
Business Overview: The company manufactures surgical products and uniforms. As of the report date, 8,133,552 common shares were outstanding.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 1995 | Nine Months Ended Sep 30, 1995 |
|---|---|---|
| Net Sales | $33,267,467 | $100,429,444 |
| Net Earnings | $2,011,434 | $6,256,377 |
| Earnings Per Share (EPS) | $0.24 | $0.75 |
| Operating Cash Flow | N/A | $6,193,610 |
| Cash and Certificates of Deposit | $9,074,401 (Balance) | $9,074,401 (Balance) |
| Total Debt (Current + Long-Term) | $18,900,000 | $18,900,000 |
| Cost of Goods Sold Margin | 66.8% | 66.7% |
| Selling & Admin Expense Margin | 22.7% | 22.5% |
Material Changes vs. Prior Period
- Revenue: Net sales for the nine months ended September 30, 1995, decreased by approximately 1% compared to the same period in 1994 ($100.4M vs. $101.0M). Quarterly sales were flat compared to the prior year.
- Profitability: Net earnings for the quarter decreased 18% to $2.01M from $2.46M in the prior year quarter, attributed to higher costs. Nine-month net earnings decreased to $6.26M from $7.31M.
- Inventory: Inventories increased 9% to $44.7M from $41.0M at year-end 1994 to support expected future demand and new uniform designs.
- Debt: Total debt decreased by $300,000 to $18.9M due to scheduled repayments. Interest expense decreased 4% year-over-year.
- Liquidity: Cash and certificates of deposit decreased by $2.16M to $9.07M, primarily due to normal operations and capital expenditures.
Outlook, Risks, and Contingencies
Management Commentary and Outlook
Management notes that sales were flat in the third quarter due to a general economic slowdown in served marketplaces. The company expects to continue its capital expenditure program to maintain facilities. Management believes cash flow from operations and existing credit facilities will be adequate for foreseeable funding requirements.
Legal Proceedings and Contingencies
Federal Investigation: The company is a target of a Federal criminal and civil investigation regarding alleged false statements and claims related to contracts with the U.S. Department of Veterans Affairs (1983-1992). A former vice president has entered a plea agreement. The company has recorded a $2.25M liability for a dispute settlement offer made in 1993, which was rejected by authorities. The company cannot estimate the outcome but asserts specific defenses.
Collateral Consequences: Potential indictment or conviction could lead to suspension or debarment from future Federal government contracts. Management believes this would not have a material adverse effect on the company but may impede access to certain Federal grant programs.
Credit Facilities
The company has a revolving credit agreement with $9.0M available. It is in full compliance with all covenants, including minimum working capital of $20M and tangible net worth of $55M.
Investor Verification Checklist
- Legal Exposure: Verify the current status of the Federal criminal/civil investigation and the likelihood of the $2.25M settlement liability being sufficient or if additional charges are probable.
- Government Contract Dependency: Assess the percentage of revenue derived from Federal contracts to gauge the actual impact of potential debarment.
- Inventory Build-up: Confirm that the 9% increase in inventory aligns with actual order books and does not signal future write-downs.
- Margin Pressure: Investigate the specific drivers of the "higher costs" cited by management that led to an 18% drop in quarterly net earnings despite flat sales.
- Share Repurchases: Note the authorization to retire 230,000 shares in October 1995 for $2.19M and its impact on future EPS.